Clinical Trial Update: The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing whether GLP-1 receptor agonists influence blood lipoprotein(a) levels in people with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: UNKNOWN